TY - JOUR AU - Williams, R. E. AU - Kalilani, L. AU - DiBenedetti, D. B. AU - Zhou, X. AU - Granger, A. L. AU - Fehnel, S. E. AU - Levine, K. B. AU - Jordan, J. AU - Clark, R. V. PY - 2008 DA - 2008// TI - Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States JO - Climacteric VL - 11 UR - https://doi.org/10.1080/13697130701744696 DO - 10.1080/13697130701744696 ID - Williams2008 ER - TY - JOUR AU - Mac Bride, M. B. AU - Rhodes, D. J. AU - Shuster, L. T. PY - 2010 DA - 2010// TI - Vulvovaginal atrophy JO - Mayo Clin Proc VL - 85 UR - https://doi.org/10.4065/mcp.2009.0413 DO - 10.4065/mcp.2009.0413 ID - Mac Bride2010 ER - TY - JOUR AU - Riggs, B. L. AU - Khosla, S. AU - Melton, L. J. PY - 1998 DA - 1998// TI - A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men JO - J Bone Miner Res VL - 13 UR - https://doi.org/10.1359/jbmr.1998.13.5.763 DO - 10.1359/jbmr.1998.13.5.763 ID - Riggs1998 ER - TY - STD TI - National Osteoporosis Foundation: What women need to know. http://www.nof.org/articles/235, UR - http://www.nof.org/articles/235 ID - ref4 ER - TY - STD TI - The 2012 hormone therapy position statement of The North American Menopause Society. Menopause. 2012, 19: 257-271. ID - ref5 ER - TY - JOUR AU - Chen, W. Y. AU - Manson, J. E. AU - Hankinson, S. E. AU - Rosner, B. AU - Holmes, M. D. AU - Willett, W. C. AU - Colditz, G. A. PY - 2006 DA - 2006// TI - Unopposed estrogen therapy and the risk of invasive breast cancer JO - Arch Intern Med VL - 166 UR - https://doi.org/10.1001/archinte.166.9.1027 DO - 10.1001/archinte.166.9.1027 ID - Chen2006 ER - TY - JOUR AU - Barnabei, V. M. AU - Cochrane, B. B. AU - Aragaki, A. K. AU - Nygaard, I. AU - Williams, R. S. AU - McGovern, P. G. AU - Young, R. L. AU - Wells, E. C. AU - O’Sullivan, M. J. AU - Chen, B. AU - Schenken, R. AU - Johnson, S. R. PY - 2005 DA - 2005// TI - Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women’s Health Initiative JO - Obstet Gynecol VL - 105 UR - https://doi.org/10.1097/01.AOG.0000158120.47542.18 DO - 10.1097/01.AOG.0000158120.47542.18 ID - Barnabei2005 ER - TY - JOUR AU - Chlebowski, R. T. AU - Hendrix, S. L. AU - Langer, R. D. AU - Stefanick, M. L. AU - Gass, M. AU - Lane, D. AU - Rodabough, R. J. AU - Gilligan, M. A. AU - Cyr, M. G. AU - Thomson, C. A. AU - Khandekar, J. AU - Petrovitch, H. AU - McTiernan, A. PY - 2003 DA - 2003// TI - Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial JO - JAMA VL - 289 UR - https://doi.org/10.1001/jama.289.24.3243 DO - 10.1001/jama.289.24.3243 ID - Chlebowski2003 ER - TY - JOUR AU - Pickar, J. H. AU - Yeh, I. T. AU - Bachmann, G. AU - Speroff, L. PY - 2009 DA - 2009// TI - Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy JO - Fertil Steril VL - 92 UR - https://doi.org/10.1016/j.fertnstert.2009.05.094 DO - 10.1016/j.fertnstert.2009.05.094 ID - Pickar2009 ER - TY - JOUR AU - Lobo, R. A. AU - Pinkerton, J. V. AU - Gass, M. L. AU - Dorin, M. H. AU - Ronkin, S. AU - Pickar, J. H. AU - Constantine, G. PY - 2009 DA - 2009// TI - Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile JO - Fertil Steril VL - 92 UR - https://doi.org/10.1016/j.fertnstert.2009.03.113 DO - 10.1016/j.fertnstert.2009.03.113 ID - Lobo2009 ER - TY - JOUR AU - Archer, D. F. AU - Lewis, V. AU - Carr, B. R. AU - Olivier, S. AU - Pickar, J. H. PY - 2009 DA - 2009// TI - Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women JO - Fertil Steril VL - 92 UR - https://doi.org/10.1016/j.fertnstert.2009.05.093 DO - 10.1016/j.fertnstert.2009.05.093 ID - Archer2009 ER - TY - JOUR AU - Lindsay, R. AU - Gallagher, J. C. AU - Kagan, R. AU - Pickar, J. H. AU - Constantine, G. PY - 2009 DA - 2009// TI - Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women JO - Fertil Steril VL - 92 UR - https://doi.org/10.1016/j.fertnstert.2009.02.093 DO - 10.1016/j.fertnstert.2009.02.093 ID - Lindsay2009 ER - TY - JOUR AU - Pinkerton, J. V. AU - Utian, W. H. AU - Constantine, G. D. AU - Olivier, S. AU - Pickar, J. H. PY - 2009 DA - 2009// TI - Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e3181a7df0d DO - 10.1097/gme.0b013e3181a7df0d ID - Pinkerton2009 ER - TY - JOUR AU - Utian, W. AU - Yu, H. AU - Bobula, J. AU - Mirkin, S. AU - Olivier, S. AU - Pickar, J. H. PY - 2009 DA - 2009// TI - Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women JO - Maturitas VL - 63 UR - https://doi.org/10.1016/j.maturitas.2009.06.006 DO - 10.1016/j.maturitas.2009.06.006 ID - Utian2009 ER - TY - JOUR AU - Kagan, R. AU - Williams, R. S. AU - Pan, K. AU - Mirkin, S. AU - Pickar, J. H. PY - 2010 DA - 2010// TI - A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women JO - Menopause VL - 17 UR - https://doi.org/10.1097/gme.0b013e3181b7c65f DO - 10.1097/gme.0b013e3181b7c65f ID - Kagan2010 ER - TY - JOUR AU - Bachmann, G. AU - Bobula, J. AU - Mirkin, S. PY - 2010 DA - 2010// TI - Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy JO - Climacteric VL - 13 UR - https://doi.org/10.3109/13697130903305627 DO - 10.3109/13697130903305627 ID - Bachmann2010 ER - TY - JOUR AU - Mirkin, S. AU - Komm, B. S. AU - Pan, K. AU - Chines, A. A. PY - 2013 DA - 2013// TI - Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women JO - Climacteric VL - 16 UR - https://doi.org/10.3109/13697137.2012.717994 DO - 10.3109/13697137.2012.717994 ID - Mirkin2013 ER - TY - JOUR AU - Pinkerton, J. V. AU - Harvey, J. A. AU - Pan, K. AU - Thompson, J. R. AU - Ryan, K. A. AU - Chines, A. A. AU - Mirkin, S. PY - 2013 DA - 2013// TI - Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial JO - Obstet Gynecol VL - 121 UR - https://doi.org/10.1097/AOG.0b013e31828c5974 DO - 10.1097/AOG.0b013e31828c5974 ID - Pinkerton2013 ER - TY - JOUR AU - Pinkerton, J. V. AU - Pan, K. AU - Abraham, L. AU - Racketa, J. AU - Ryan, K. A. AU - Chines, A. A. AU - Mirkin, S. PY - 2014 DA - 2014// TI - Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial JO - Menopause VL - 21 UR - https://doi.org/10.1097/GME.0b013e31829f0433 DO - 10.1097/GME.0b013e31829f0433 ID - Pinkerton2014 ER - TY - JOUR AU - Pinkerton, J. V. AU - Harvey, J. A. AU - Lindsay, R. AU - Pan, K. AU - Chines, A. A. AU - Mirkin, S. AU - Archer, D. F. PY - 2014 DA - 2014// TI - Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial JO - J Clin Endocrinol Metab VL - 99 UR - https://doi.org/10.1210/jc.2013-1707 DO - 10.1210/jc.2013-1707 ID - Pinkerton2014 ER - TY - JOUR AU - Crandall, C. J. AU - Aragaki, A. K. AU - Cauley, J. A. AU - McTiernan, A. AU - Manson, J. E. AU - Anderson, G. L. AU - Wactawski-Wende, J. AU - Chlebowski, R. T. PY - 2012 DA - 2012// TI - Breast tenderness after initiation of conjugated equine estrogens and mammographic density change JO - Breast Cancer Res Treat VL - 131 UR - https://doi.org/10.1007/s10549-011-1803-9 DO - 10.1007/s10549-011-1803-9 ID - Crandall2012 ER - TY - JOUR AU - McTiernan, A. AU - Martin, C. F. AU - Peck, J. D. AU - Aragaki, A. K. AU - Chlebowski, R. T. AU - Pisano, E. D. AU - Wang, C. Y. AU - Brunner, R. L. AU - Johnson, K. C. AU - Manson, J. E. AU - Lewis, C. E. AU - Kotchen, J. M. AU - Hulka, B. S. PY - 2005 DA - 2005// TI - Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women’s Health Initiative randomized trial JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji279 DO - 10.1093/jnci/dji279 ID - McTiernan2005 ER - TY - JOUR AU - Anderson, G. L. AU - Limacher, M. AU - Assaf, A. R. AU - Bassford, T. AU - Beresford, S. A. AU - Black, H. AU - Bonds, D. AU - Brunner, R. AU - Brzyski, R. AU - Caan, B. AU - Chlebowski, R. AU - Curb, D. AU - Gass, M. AU - Hays, J. AU - Heiss, G. AU - Hendrix, S. AU - Howard, B. V. AU - Hsia, J. AU - Hubbell, A. AU - Jackson, R. AU - Johnson, K. C. AU - Judd, H. AU - Kotchen, J. M. AU - Kuller, L. AU - LaCroix, A. Z. AU - Lane, D. AU - Langer, R. D. AU - Lasser, N. AU - Lewis, C. E. AU - Manson, J. PY - 2004 DA - 2004// TI - Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.14.1701 DO - 10.1001/jama.291.14.1701 ID - Anderson2004 ER - TY - JOUR AU - Anderson, G. L. AU - Chlebowski, R. T. AU - Aragaki, A. K. AU - Kuller, L. H. AU - Manson, J. E. AU - Gass, M. AU - Bluhm, E. AU - Connelly, S. AU - Hubbell, F. A. AU - Lane, D. AU - Martin, L. AU - Ockene, J. AU - Rohan, T. AU - Schenken, R. AU - Wactawski-Wende, J. PY - 2012 DA - 2012// TI - Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomised placebo-controlled trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70075-X DO - 10.1016/S1470-2045(12)70075-X ID - Anderson2012 ER - TY - JOUR AU - Chlebowski, R. T. AU - Anderson, G. L. AU - Gass, M. AU - Lane, D. S. AU - Aragaki, A. K. AU - Kuller, L. H. AU - Manson, J. E. AU - Stefanick, M. L. AU - Ockene, J. AU - Sarto, G. E. AU - Johnson, K. C. AU - Wactawski-Wende, J. AU - Ravdin, P. M. AU - Schenken, R. AU - Hendrix, S. L. AU - Rajkovic, A. AU - Rohan, T. E. AU - Yasmeen, S. AU - Prentice, R. L. PY - 2010 DA - 2010// TI - Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1500 DO - 10.1001/jama.2010.1500 ID - Chlebowski2010 ER - TY - JOUR AU - Kenemans, P. AU - Bosman, A. PY - 2003 DA - 2003// TI - Breast cancer and post-menopausal hormone therapy JO - Best Pract Res Clin Endocrinol Metab VL - 17 UR - https://doi.org/10.1016/S1521-690X(02)00084-2 DO - 10.1016/S1521-690X(02)00084-2 ID - Kenemans2003 ER - TY - JOUR AU - Santen, R. J. AU - Yue, W. AU - Heitjan, D. F. PY - 2012 DA - 2012// TI - Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy JO - Cancer Epidemiol Biomarkers Prev VL - 21 UR - https://doi.org/10.1158/1055-9965.EPI-12-0043 DO - 10.1158/1055-9965.EPI-12-0043 ID - Santen2012 ER - TY - JOUR AU - Cavalieri, E. L. AU - Stack, D. E. AU - Devanesan, P. D. AU - Todorovic, R. AU - Dwivedy, I. AU - Higginbotham, S. AU - Johansson, S. L. AU - Patil, K. D. AU - Gross, M. L. AU - Gooden, J. K. AU - Ramanathan, R. AU - Cerny, R. L. AU - Rogan, E. G. PY - 1997 DA - 1997// TI - Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators JO - Proc Natl Acad Sci U S A VL - 94 UR - https://doi.org/10.1073/pnas.94.20.10937 DO - 10.1073/pnas.94.20.10937 ID - Cavalieri1997 ER - TY - JOUR AU - Song, Y. AU - Santen, R. J. AU - Wang, J. P. AU - Yue, W. PY - 2013 DA - 2013// TI - Inhibitory effects of a bazedoxifene/conjugated equine estrogen combination on human breast cancer cells in vitro JO - Endocrinology VL - 154 UR - https://doi.org/10.1210/en.2012-2038 DO - 10.1210/en.2012-2038 ID - Song2013 ER - TY - JOUR AU - Song, Y. AU - Santen, R. J. AU - Wang, J. P. AU - Yue, W. PY - 2012 DA - 2012// TI - Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice JO - Endocrinology VL - 153 UR - https://doi.org/10.1210/en.2012-1583 DO - 10.1210/en.2012-1583 ID - Song2012 ER - TY - JOUR AU - Obr, A. E. AU - Edwards, D. P. PY - 2012 DA - 2012// TI - The biology of progesterone receptor in the normal mammary gland and in breast cancer JO - Mol Cell Endocrinol VL - 357 UR - https://doi.org/10.1016/j.mce.2011.10.030 DO - 10.1016/j.mce.2011.10.030 ID - Obr2012 ER - TY - JOUR AU - Axlund, S. D. AU - Sartorius, C. A. PY - 2012 DA - 2012// TI - Progesterone regulation of stem and progenitor cells in normal and malignant breast JO - Mol Cell Endocrinol VL - 357 UR - https://doi.org/10.1016/j.mce.2011.09.021 DO - 10.1016/j.mce.2011.09.021 ID - Axlund2012 ER - TY - JOUR AU - Liang, Y. AU - Benakanakere, I. AU - Besch-Williford, C. AU - Hyder, R. S. AU - Ellersieck, M. R. AU - Hyder, S. M. PY - 2010 DA - 2010// TI - Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice JO - Menopause VL - 17 UR - https://doi.org/10.1097/gme.0b013e3181d3dd0c DO - 10.1097/gme.0b013e3181d3dd0c ID - Liang2010 ER - TY - JOUR AU - Tkach, M. AU - Rosemblit, C. AU - Rivas, M. A. AU - Proietti, C. J. AU - Diaz Flaque, M. C. AU - Mercogliano, M. F. AU - Beguelin, W. AU - Maronna, E. AU - Guzman, P. AU - Gercovich, F. G. AU - Deza, E. G. AU - Elizalde, P. V. AU - Schillaci, R. PY - 2013 DA - 2013// TI - p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth JO - Endocr Relat Cancer VL - 20 UR - https://doi.org/10.1530/ERC-12-0194 DO - 10.1530/ERC-12-0194 ID - Tkach2013 ER - TY - JOUR AU - Brisken, C. PY - 2013 DA - 2013// TI - Progesterone signalling in breast cancer: a neglected hormone coming into the limelight JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3518 DO - 10.1038/nrc3518 ID - Brisken2013 ER - TY - JOUR AU - Rivas, M. A. AU - Venturutti, L. AU - Huang, Y. W. AU - Schillaci, R. AU - Huang, T. H. AU - Elizalde, P. V. PY - 2012 DA - 2012// TI - Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development JO - Breast Cancer Res VL - 14 UR - https://doi.org/10.1186/bcr3187 DO - 10.1186/bcr3187 ID - Rivas2012 ER - TY - JOUR AU - Lopez Perez, F. R. AU - Liang, Y. AU - Besch-Williford, C. L. AU - Mafuvadze, B. AU - Hyder, S. M. PY - 2012 DA - 2012// TI - Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model JO - Histol Histopathol VL - 27 ID - Lopez Perez2012 ER - TY - JOUR AU - Boyd, N. F. AU - Rommens, J. M. AU - Vogt, K. AU - Lee, V. AU - Hopper, J. L. AU - Yaffe, M. J. AU - Paterson, A. D. PY - 2005 DA - 2005// TI - Mammographic breast density as an intermediate phenotype for breast cancer JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70390-9 DO - 10.1016/S1470-2045(05)70390-9 ID - Boyd2005 ER - TY - JOUR AU - McCormack, V. A. AU - dos Santos, S. I. PY - 2006 DA - 2006// TI - Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis JO - Cancer Epidemiol Biomarkers Prev VL - 15 UR - https://doi.org/10.1158/1055-9965.EPI-06-0034 DO - 10.1158/1055-9965.EPI-06-0034 ID - McCormack2006 ER - TY - JOUR AU - Carney, P. A. AU - Miglioretti, D. L. AU - Yankaskas, B. C. AU - Kerlikowske, K. AU - Rosenberg, R. AU - Rutter, C. M. AU - Geller, B. M. AU - Abraham, L. A. AU - Taplin, S. H. AU - Dignan, M. AU - Cutter, G. AU - Ballard-Barbash, R. PY - 2003 DA - 2003// TI - Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography JO - Ann Intern Med VL - 138 UR - https://doi.org/10.7326/0003-4819-138-3-200302040-00008 DO - 10.7326/0003-4819-138-3-200302040-00008 ID - Carney2003 ER - TY - JOUR AU - Crandall, C. J. AU - Aragaki, A. K. AU - Cauley, J. A. AU - McTiernan, A. AU - Manson, J. E. AU - Anderson, G. AU - Chlebowski, R. T. PY - 2012 DA - 2012// TI - Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1848-9 DO - 10.1007/s10549-011-1848-9 ID - Crandall2012 ER - TY - JOUR AU - Riggs, B. L. AU - Hartmann, L. C. PY - 2003 DA - 2003// TI - Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMra022219 DO - 10.1056/NEJMra022219 ID - Riggs2003 ER - TY - JOUR AU - Pickar, J. H. AU - MacNeil, T. AU - Ohleth, K. PY - 2010 DA - 2010// TI - SERMs: progress and future perspectives JO - Maturitas VL - 67 UR - https://doi.org/10.1016/j.maturitas.2010.05.009 DO - 10.1016/j.maturitas.2010.05.009 ID - Pickar2010 ER - TY - JOUR AU - Jordan, V. C. AU - Morrow, M. PY - 1999 DA - 1999// TI - Tamoxifen, raloxifene, and the prevention of breast cancer JO - Endocr Rev VL - 20 ID - Jordan1999 ER - TY - JOUR AU - Jordan, V. C. AU - Phelps, E. AU - Lindgren, J. U. PY - 1987 DA - 1987// TI - Effects of anti-estrogens on bone in castrated and intact female rats JO - Breast Cancer Res Treat VL - 10 UR - https://doi.org/10.1007/BF01806132 DO - 10.1007/BF01806132 ID - Jordan1987 ER - TY - JOUR AU - Turner, C. H. AU - Sato, M. AU - Bryant, H. U. PY - 1994 DA - 1994// TI - Raloxifene preserves bone strength and bone mass in ovariectomized rats JO - Endocrinology VL - 135 ID - Turner1994 ER - TY - JOUR AU - Love, R. R. AU - Mazess, R. B. AU - Barden, H. S. AU - Epstein, S. AU - Newcomb, P. A. AU - Jordan, V. C. AU - Carbone, P. P. AU - DeMets, D. L. PY - 1992 DA - 1992// TI - Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer JO - N Engl J Med VL - 326 UR - https://doi.org/10.1056/NEJM199203263261302 DO - 10.1056/NEJM199203263261302 ID - Love1992 ER - TY - JOUR AU - Kedar, R. P. AU - Bourne, T. H. AU - Powles, T. J. AU - Collins, W. P. AU - Ashley, S. E. AU - Cosgrove, D. O. AU - Campbell, S. PY - 1994 DA - 1994// TI - Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial JO - Lancet VL - 343 UR - https://doi.org/10.1016/S0140-6736(94)92466-X DO - 10.1016/S0140-6736(94)92466-X ID - Kedar1994 ER - TY - JOUR AU - Maximov, P. Y. AU - Lee, T. M. AU - Jordan, V. C. PY - 2013 DA - 2013// TI - The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice JO - Curr Clin Pharmacol VL - 8 UR - https://doi.org/10.2174/1574884711308020006 DO - 10.2174/1574884711308020006 ID - Maximov2013 ER - TY - JOUR AU - Goldstein, S. R. AU - Bhattoa, H. P. AU - Neven, P. AU - Cox, D. A. AU - Dowsett, S. A. AU - Alam, J. AU - Sipos, A. AU - Muram, D. PY - 2012 DA - 2012// TI - Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass JO - Menopause VL - 19 UR - https://doi.org/10.1097/gme.0b013e318223bbf4 DO - 10.1097/gme.0b013e318223bbf4 ID - Goldstein2012 ER - TY - JOUR AU - Cummings, S. R. AU - McClung, M. AU - Reginster, J. Y. AU - Cox, D. AU - Mitlak, B. AU - Stock, J. AU - Amewou-Atisso, M. AU - Powles, T. AU - Miller, P. AU - Zanchetta, J. AU - Christiansen, C. PY - 2011 DA - 2011// TI - Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women JO - J Bone Miner Res VL - 26 UR - https://doi.org/10.1002/jbmr.191 DO - 10.1002/jbmr.191 ID - Cummings2011 ER - TY - JOUR AU - Powles, T. J. AU - Diem, S. J. AU - Fabian, C. J. AU - Neven, P. AU - Wickerham, D. L. AU - Cox, D. A. AU - Muram, D. AU - Agnusdei, D. AU - Dowsett, S. A. AU - Amewou-Atisso, M. AU - Cummings, S. R. PY - 2012 DA - 2012// TI - Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene JO - Breast Cancer Res Treat VL - 134 UR - https://doi.org/10.1007/s10549-012-2041-5 DO - 10.1007/s10549-012-2041-5 ID - Powles2012 ER - TY - STD TI - Osphena [package insert]. 2013, Florham Park, NJ: Shionogi Inc ID - ref53 ER - TY - STD TI - Nolvadex [package insert]. 2005, Wilmington, DE: AstraZeneca Pharmaceuticals LP ID - ref54 ER - TY - JOUR AU - Jordan, V. C. PY - 1976 DA - 1976// TI - Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata JO - Eur J Cancer VL - 12 UR - https://doi.org/10.1016/0014-2964(76)90030-X DO - 10.1016/0014-2964(76)90030-X ID - Jordan1976 ER - TY - JOUR AU - Shafie, S. M. AU - Grantham, F. H. PY - 1981 DA - 1981// TI - Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice JO - J Natl Cancer Inst VL - 67 ID - Shafie1981 ER - TY - JOUR AU - Shelly, W. AU - Draper, M. W. AU - Krishnan, V. AU - Wong, M. AU - Jaffe, R. B. PY - 2008 DA - 2008// TI - Selective estrogen receptor modulators: an update on recent clinical findings JO - Obstet Gynecol Surv VL - 63 ID - Shelly2008 ER - TY - JOUR AU - Chow, C. K. AU - Venzon, D. AU - Jones, E. C. AU - Premkumar, A. AU - O’Shaughnessy, J. AU - Zujewski, J. PY - 2000 DA - 2000// TI - Effect of tamoxifen on mammographic density JO - Cancer Epidemiol Biomarkers Prev VL - 9 ID - Chow2000 ER - TY - JOUR AU - Cuzick, J. AU - Warwick, J. AU - Pinney, E. AU - Duffy, S. W. AU - Cawthorn, S. AU - Howell, A. AU - Forbes, J. F. AU - Warren, R. M. PY - 2011 DA - 2011// TI - Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case–control study JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr079 DO - 10.1093/jnci/djr079 ID - Cuzick2011 ER - TY - STD TI - Evista [package insert]. 2011, Indianapolis, IN: Eli Lilly and Company ID - ref60 ER - TY - JOUR AU - Komm, B. S. AU - Kharode, Y. P. AU - Bodine, P. V. AU - Harris, H. A. AU - Miller, C. P. AU - Lyttle, C. R. PY - 2005 DA - 2005// TI - Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity JO - Endocrinology VL - 146 UR - https://doi.org/10.1210/en.2005-0030 DO - 10.1210/en.2005-0030 ID - Komm2005 ER - TY - JOUR AU - Chang, K. C. AU - Wang, Y. AU - Bodine, P. V. AU - Nagpal, S. AU - Komm, B. S. PY - 2010 DA - 2010// TI - Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens JO - J Steroid Biochem Mol Biol VL - 118 UR - https://doi.org/10.1016/j.jsbmb.2009.11.003 DO - 10.1016/j.jsbmb.2009.11.003 ID - Chang2010 ER - TY - JOUR AU - Lewis-Wambi, J. S. AU - Kim, H. AU - Curpan, R. AU - Grigg, R. AU - Sarker, M. A. AU - Jordan, V. C. PY - 2011 DA - 2011// TI - The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor alpha and cyclin D1 JO - Mol Pharmacol VL - 80 UR - https://doi.org/10.1124/mol.111.072249 DO - 10.1124/mol.111.072249 ID - Lewis-Wambi2011 ER - TY - JOUR AU - Crabtree, J. S. AU - Peano, B. J. AU - Zhang, X. AU - Komm, B. S. AU - Winneker, R. C. AU - Harris, H. A. PY - 2008 DA - 2008// TI - Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland JO - Mol Cell Endocrinol VL - 287 UR - https://doi.org/10.1016/j.mce.2008.01.027 DO - 10.1016/j.mce.2008.01.027 ID - Crabtree2008 ER - TY - JOUR AU - Cauley, J. A. AU - Norton, L. AU - Lippman, M. E. AU - Eckert, S. AU - Krueger, K. A. AU - Purdie, D. W. AU - Farrerons, J. AU - Karasik, A. AU - Mellstrom, D. AU - Ng, K. W. AU - Stepan, J. J. AU - Powles, T. J. AU - Morrow, M. AU - Costa, A. AU - Silfen, S. L. AU - Walls, E. L. AU - Schmitt, H. AU - Muchmore, D. B. AU - Jordan, V. C. AU - Ste-Marie, L. G. PY - 2001 DA - 2001// TI - Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation JO - Breast Cancer Res Treat VL - 65 UR - https://doi.org/10.1023/A:1006478317173 DO - 10.1023/A:1006478317173 ID - Cauley2001 ER - TY - JOUR AU - Martino, S. AU - Cauley, J. A. AU - Barrett-Connor, E. AU - Powles, T. J. AU - Mershon, J. AU - Disch, D. AU - Secrest, R. J. AU - Cummings, S. R. PY - 2004 DA - 2004// TI - Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh319 DO - 10.1093/jnci/djh319 ID - Martino2004 ER - TY - JOUR AU - Barrett-Connor, E. AU - Mosca, L. AU - Collins, P. AU - Geiger, M. J. AU - Grady, D. AU - Kornitzer, M. AU - McNabb, M. A. AU - Wenger, N. K. PY - 2006 DA - 2006// TI - Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa062462 DO - 10.1056/NEJMoa062462 ID - Barrett-Connor2006 ER - TY - JOUR AU - Vogel, V. G. AU - Costantino, J. P. AU - Wickerham, D. L. AU - Cronin, W. M. AU - Cecchini, R. S. AU - Atkins, J. N. AU - Bevers, T. B. AU - Fehrenbacher, L. AU - Pajon, E. R. AU - Wade, J. L. AU - Robidoux, A. AU - Margolese, R. G. AU - James, J. AU - Runowicz, C. D. AU - Ganz, P. A. AU - Reis, S. E. AU - McCaskill-Stevens, W. AU - Ford, L. G. AU - Jordan, V. C. AU - Wolmark, N. PY - 2010 DA - 2010// TI - Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancer JO - Cancer Prev Res (Phila) VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0076 DO - 10.1158/1940-6207.CAPR-10-0076 ID - Vogel2010 ER - TY - JOUR AU - Voss, S. AU - Quail, D. AU - Dawson, A. AU - Backstrom, T. AU - Aguas, F. AU - Erenus, M. AU - The, H. S. AU - Bonnar, J. AU - De, G. C. AU - Hunter, M. AU - Nickelsen, T. PY - 2002 DA - 2002// TI - A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life JO - BJOG VL - 109 UR - https://doi.org/10.1111/j.1471-0528.2002.01510.x DO - 10.1111/j.1471-0528.2002.01510.x ID - Voss2002 ER - TY - JOUR AU - Pearman, L. AU - Kagan, R. AU - Arsenault, J. AU - Muram, D. PY - 2010 DA - 2010// TI - The effects of raloxifene on mammographic breast density: a review of clinical trials JO - Menopause VL - 17 ID - Pearman2010 ER - TY - JOUR AU - Freedman, M. AU - San, M. J. AU - O’Gorman, J. AU - Eckert, S. AU - Lippman, M. E. AU - Lo, S. C. AU - Walls, E. L. AU - Zeng, J. PY - 2001 DA - 2001// TI - Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.1.51 DO - 10.1093/jnci/93.1.51 ID - Freedman2001 ER - TY - JOUR AU - Jackson, V. P. AU - San Martin, J. A. AU - Secrest, R. J. AU - McNabb, M. AU - Carranza-Lira, S. AU - Figueroa-Casas, P. AU - Fernandes, C. E. AU - Romaguera, J. PY - 2003 DA - 2003// TI - Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women JO - Am J Obstet Gynecol VL - 188 UR - https://doi.org/10.1067/mob.2003.21 DO - 10.1067/mob.2003.21 ID - Jackson2003 ER - TY - JOUR AU - Eilertsen, A. L. AU - Karssemeijer, N. AU - Skaane, P. AU - Qvigstad, E. AU - Sandset, P. M. PY - 2008 DA - 2008// TI - Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method JO - BJOG VL - 115 UR - https://doi.org/10.1111/j.1471-0528.2008.01690.x DO - 10.1111/j.1471-0528.2008.01690.x ID - Eilertsen2008 ER - TY - JOUR AU - Gennari, L. PY - 2009 DA - 2009// TI - Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy JO - Expert Opin Pharmacother VL - 10 UR - https://doi.org/10.1517/14656560903127241 DO - 10.1517/14656560903127241 ID - Gennari2009 ER - TY - JOUR AU - Rosati, R. L. AU - Da Silva, J. P. AU - Cameron, K. O. AU - Thompson, D. D. AU - Ke, H. Z. AU - Toler, S. M. AU - Brown, T. A. AU - Pan, L. C. AU - Ebbinghaus, C. F. AU - Reinhold, A. R. AU - Elliott, N. C. AU - Newhouse, B. N. AU - Tjoa, C. M. AU - Sweetnam, P. M. AU - Cole, M. J. AU - Arriola, M. W. AU - Gauthier, J. W. AU - Crawford, D. T. AU - Nickerson, D. F. AU - Pirie, C. M. AU - Qi, H. AU - Simmons, H. A. AU - Tkalcevic, G. T. PY - 1998 DA - 1998// TI - Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene JO - J Med Chem VL - 41 UR - https://doi.org/10.1021/jm980048b DO - 10.1021/jm980048b ID - Rosati1998 ER - TY - JOUR AU - Cline, J. M. AU - Botts, S. AU - Lees, C. J. AU - Brommage, R. PY - 2008 DA - 2008// TI - Effects of lasofoxifene on the uterus, vagina, and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis) JO - Am J Obstet Gynecol VL - 199 UR - https://doi.org/10.1016/j.ajog.2008.02.020 DO - 10.1016/j.ajog.2008.02.020 ID - Cline2008 ER - TY - JOUR AU - LaCroix, A. Z. AU - Powles, T. AU - Osborne, C. K. AU - Wolter, K. AU - Thompson, J. R. AU - Thompson, D. D. AU - Allred, D. C. AU - Armstrong, R. AU - Cummings, S. R. AU - Eastell, R. AU - Ensrud, K. E. AU - Goss, P. AU - Lee, A. AU - Neven, P. AU - Reid, D. M. AU - Curto, M. AU - Vukicevic, S. PY - 2010 DA - 2010// TI - Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq415 DO - 10.1093/jnci/djq415 ID - LaCroix2010 ER - TY - JOUR AU - Davidson, M. AU - Moffett, A. AU - Welty, F. AU - Simon, J. AU - Bolognese, M. AU - de Melo, N. AU - Wolter, K. AU - Proulx, J. AU - Radecki, D. PY - 2005 DA - 2005// TI - Extraskeletal effects of lasofoxifene on postmenopausal women [abstract SA428] JO - J Bone Miner Res VL - 20 ID - Davidson2005 ER - TY - STD TI - Fablyn®. Ligand. http://www.ligand.com/fablyn, UR - http://www.ligand.com/fablyn ID - ref79 ER - TY - STD TI - Ligand inks week’s second lasofoxifene licensing deal. Genet Eng Biotechnol News. http://www.genengnews.com/gen-news-highlights/ligand-inks-week-s-second-lasofoxifene-licensing-deal/81248637/, UR - http://www.genengnews.com/gen-news-highlights/ligand-inks-week-s-second-lasofoxifene-licensing-deal/81248637/ ID - ref80 ER - TY - JOUR AU - Miller, P. D. AU - Chines, A. A. AU - Christiansen, C. AU - Hoeck, H. C. AU - Kendler, D. L. AU - Lewiecki, E. M. AU - Woodson, G. AU - Levine, A. B. AU - Constantine, G. AU - Delmas, P. D. PY - 2008 DA - 2008// TI - Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study JO - J Bone Miner Res VL - 23 UR - https://doi.org/10.1359/jbmr.071206 DO - 10.1359/jbmr.071206 ID - Miller2008 ER - TY - JOUR AU - Silverman, S. L. AU - Christiansen, C. AU - Genant, H. K. AU - Vukicevic, S. AU - Zanchetta, J. R. AU - de Villiers, T. J. AU - Constantine, G. D. AU - Chines, A. A. PY - 2008 DA - 2008// TI - Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial JO - J Bone Miner Res VL - 23 UR - https://doi.org/10.1359/jbmr.080710 DO - 10.1359/jbmr.080710 ID - Silverman2008 ER - TY - JOUR AU - Komm, B. S. AU - Lyttle, C. R. PY - 2001 DA - 2001// TI - Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation JO - Ann N Y Acad Sci VL - 949 UR - https://doi.org/10.1111/j.1749-6632.2001.tb04039.x DO - 10.1111/j.1749-6632.2001.tb04039.x ID - Komm2001 ER - TY - JOUR AU - Santen, R. J. AU - Kagan, R. AU - Altomare, C. J. AU - Komm, B. AU - Mirkin, S. AU - Taylor, H. S. PY - 2014 DA - 2014// TI - Current and evolving approaches to individualizing estrogen receptor-based therapy approaches for menopausal women JO - J Clin Endocrinol Metab VL - 99 UR - https://doi.org/10.1210/jc.2013-3680 DO - 10.1210/jc.2013-3680 ID - Santen2014 ER - TY - CHAP AU - Mirkin, S. AU - Archer, D. F. AU - Taylor, H. S. AU - Pickar, J. H. AU - Komm, B. S. PY - 2014 DA - 2014// TI - Differential effects of menopausal therapies on the endometrium BT - Menopause ID - Mirkin2014 ER - TY - JOUR AU - Wardell, S. E. AU - Nelson, E. R. AU - Chao, C. A. AU - McDonnell, D. P. PY - 2013 DA - 2013// TI - Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3771 DO - 10.1158/1078-0432.CCR-12-3771 ID - Wardell2013 ER - TY - JOUR AU - Pinkerton, J. V. AU - Archer, D. F. AU - Utian, W. H. AU - Menegoci, J. C. AU - Levine, A. B. AU - Chines, A. A. AU - Constantine, G. D. PY - 2009 DA - 2009// TI - Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e3181a816be DO - 10.1097/gme.0b013e3181a816be ID - Pinkerton2009 ER - TY - JOUR AU - Archer, D. F. AU - Pinkerton, J. V. AU - Utian, W. H. AU - Menegoci, J. C. AU - de Villiers, T. J. AU - Yuen, C. K. AU - Levine, A. B. AU - Chines, A. A. AU - Constantine, G. D. PY - 2009 DA - 2009// TI - Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e3181a818db DO - 10.1097/gme.0b013e3181a818db ID - Archer2009 ER - TY - JOUR AU - Christiansen, C. AU - Chesnut, C. H. AU - Adachi, J. D. AU - Brown, J. P. AU - Fernandes, C. E. AU - Kung, A. W. AU - Palacios, S. AU - Levine, A. B. AU - Chines, A. A. AU - Constantine, G. D. PY - 2010 DA - 2010// TI - Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis JO - BMC Musculoskelet Disord VL - 11 UR - https://doi.org/10.1186/1471-2474-11-130 DO - 10.1186/1471-2474-11-130 ID - Christiansen2010 ER - TY - JOUR AU - Harvey, J. A. AU - Holm, M. K. AU - Ranganath, R. AU - Guse, P. A. AU - Trott, E. A. AU - Helzner, E. PY - 2009 DA - 2009// TI - The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e3181a7fb1e DO - 10.1097/gme.0b013e3181a7fb1e ID - Harvey2009 ER - TY - JOUR AU - de Villiers, T. J. AU - Chines, A. A. AU - Palacios, S. AU - Lips, P. AU - Sawicki, A. Z. AU - Levine, A. B. AU - Codreanu, C. AU - Kelepouris, N. AU - Brown, J. P. PY - 2011 DA - 2011// TI - Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial JO - Osteoporos Int VL - 22 UR - https://doi.org/10.1007/s00198-010-1302-6 DO - 10.1007/s00198-010-1302-6 ID - de Villiers2011 ER - TY - JOUR AU - Palacios, S. AU - de Villiers, T. J. AU - Nardone, F. C. AU - Levine, A. B. AU - Williams, R. AU - Hines, T. AU - Mirkin, S. AU - Chines, A. A. PY - 2013 DA - 2013// TI - Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study JO - Maturitas VL - 76 UR - https://doi.org/10.1016/j.maturitas.2013.06.008 DO - 10.1016/j.maturitas.2013.06.008 ID - Palacios2013 ER - TY - JOUR AU - Kharode, Y. AU - Bodine, P. V. AU - Miller, C. P. AU - Lyttle, C. R. AU - Komm, B. S. PY - 2008 DA - 2008// TI - The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention JO - Endocrinology VL - 149 UR - https://doi.org/10.1210/en.2008-0817 DO - 10.1210/en.2008-0817 ID - Kharode2008 ER - TY - JOUR AU - de Villiers, T. J. AU - Pines, A. AU - Panay, N. AU - Gambacciani, M. AU - Archer, D. F. AU - Baber, R. J. AU - Davis, S. R. AU - Gompel, A. A. AU - Henderson, V. W. AU - Langer, R. AU - Lobo, R. A. AU - Plu-Bureau AU - Sturdee, D. W. PY - 2013 DA - 2013// TI - Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health JO - Climacteric VL - 16 UR - https://doi.org/10.3109/13697137.2013.795683 DO - 10.3109/13697137.2013.795683 ID - de Villiers2013 ER - TY - JOUR AU - Liu, S. AU - Han, S. J. AU - Smith, C. L. PY - 2013 DA - 2013// TI - Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes JO - Mol Pharmacol VL - 83 UR - https://doi.org/10.1124/mol.112.084228 DO - 10.1124/mol.112.084228 ID - Liu2013 ER - TY - JOUR AU - Wardell, S. E. AU - Kazmin, D. AU - McDonnell, D. P. PY - 2012 DA - 2012// TI - Research resource: transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes JO - Mol Endocrinol VL - 26 UR - https://doi.org/10.1210/me.2012-1031 DO - 10.1210/me.2012-1031 ID - Wardell2012 ER - TY - JOUR AU - Berrodin, T. J. AU - Chang, K. C. AU - Komm, B. S. AU - Freedman, L. P. AU - Nagpal, S. PY - 2009 DA - 2009// TI - Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination JO - Mol Endocrinol VL - 23 UR - https://doi.org/10.1210/me.2008-0366 DO - 10.1210/me.2008-0366 ID - Berrodin2009 ER - TY - JOUR AU - Peano, B. J. AU - Crabtree, J. S. AU - Komm, B. S. AU - Winneker, R. C. AU - Harris, H. A. PY - 2009 DA - 2009// TI - Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland JO - Endocrinology VL - 150 UR - https://doi.org/10.1210/en.2008-1210 DO - 10.1210/en.2008-1210 ID - Peano2009 ER - TY - JOUR AU - Ethun, K. F. AU - Wood, C. E. AU - Register, T. C. AU - Cline, J. M. AU - Appt, S. E. AU - Clarkson, T. B. PY - 2012 DA - 2012// TI - Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys JO - Menopause VL - 19 ID - Ethun2012 ER - TY - JOUR AU - Harvey, J. A. AU - Pinkerton, J. V. AU - Baracat, E. C. AU - Shi, H. AU - Chines, A. A. AU - Mirkin, S. PY - 2013 DA - 2013// TI - Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens JO - Menopause VL - 20 ID - Harvey2013 ER - TY - JOUR AU - Gallagher, J. C. AU - Lindsay, R. AU - Pan, K. AU - Mirkin, S. AU - Chines, A. PY - 2011 DA - 2011// TI - Effects of bazedoxifene/conjugated estrogens on bone mineral density and bone turnover markers in postmenopausal women: a double-blind, randomized, placebo- and active-controlled phase 3 study [abstract 1133] JO - J Bone Miner Res VL - 26 ID - Gallagher2011 ER - TY - JOUR AU - Archer, D. F. AU - Lobo, R. A. AU - Pan, K. AU - Chines, A. A. AU - Mirkin, S. PY - 2011 DA - 2011// TI - Safety and tolerability of bazedoxifene/conjugated estrogens in postmenopausal women: findings from a 1-year, randomized, placebo- and active-controlled, phase 3 trial [abstract P-25] JO - Menopause VL - 18 ID - Archer2011 ER - TY - STD TI - Duavee [package insert]. 2013, Philadelphia, PA: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc ID - ref103 ER - TY - JOUR AU - Pinkerton, J. V. AU - Taylor, H. AU - Pan, K. AU - Chines, A. PY - 2010 DA - 2010// TI - Breast parameters with bazedoxifene/conjugated estrogens in randomized, controlled trials of postmenopausal women [abstract] JO - Menopause VL - 17 ID - Pinkerton2010 ER -